SCHEMBL8613403

SCHEMBL8613403

Cc1ccc(NC(=S)Nc2ccc(C=Cc3ccc(NC(=S)Nc4ccc(C)cc4)cc3S(=O)(=O)O)c(S(=O)(=O)O)c2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ENPP2 Q13822 2/20 0.59
▸ QPCT Q16769 1/20 0.48
▸ RAD51 Q06609 1/20 0.47
▸ MAPT P10636 4/20 0.47
▸ MEN1 O00255 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ GAA P10253 2/20 0.43
▸ TDP1 Q9NUW8 2/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ L3MBTL1 Q9Y468 3/20 0.43
▸ RAD1 O60671 1/20 0.43
▸ P2RY6 Q15077 1/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ ALDH1A1 P00352 3/20 0.42
▸ KDM4E B2RXH2 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8614023 0.87 ENPP2 (0.57) ENPP2RAD51MAPTMEN1KMT2A
SCHEMBL14361802 0.86 ENPP2 (0.62) ENPP2RAD51MAPTCYP1A2CYP3A4
SCHEMBL14361809 0.86 ENPP2 (0.62) ENPP2RAD51MAPTCYP1A2CYP3A4
SCHEMBL19726887 0.85 ENPP2 (0.52) ENPP2RAD51MAPTHTTL3MBTL1
SCHEMBL19726895 0.84 ENPP2 (0.49) ENPP2RAD51MAPTMEN1KMT2A
SCHEMBL14361680 0.82 ENPP2 (0.58) ENPP2RAD51MAPTHTTL3MBTL1
SCHEMBL14361673 0.82 ENPP2 (0.58) ENPP2RAD51MAPTHTTL3MBTL1
SCHEMBL8613300 0.81 ENPP2 (0.53) ENPP2RAD51MAPTKMT2AGAA
SCHEMBL8609894 0.81 MAPT (0.47) QPCTMAPTMEN1KMT2ACYP1A2
SCHEMBL14358754 0.80 ENPP2 (0.74) ENPP2RAD51MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0626945-B1 SULFONIC ACID DERIVATIVES IN THE TREATMENT OF VIRAL DISEASES MERRELL PHARMA INC (US) 1998-04-22 — — EP claimed
EP-0626945-A1 SULFONIC ACID DERIVATIVES IN THE TREATMENT OF VIRAL DISEASES MERRELL PHARMACEUTICALS INC. (US) 1994-12-07 — — EP claimed
US-5359131-A Sulfonic acid derivatives in the treatment of viral diseases MERRELL DOW PHARMACEUTICALS INC. (US) 1994-10-25 — — US claimed
WO-1993016992-A1 SULFONIC ACID DERIVATIVES IN THE TREATMENT OF VIRAL DISEASES MERRELL DOW PHARMACEUTICALS INC. (US) 1993-09-02 — — WO claimed
EP-0626945-B1 SULFONIC ACID DERIVATIVES IN THE TREATMENT OF VIRAL DISEASES MERRELL PHARMA INC (US) 1998-04-22 — — EP disclosed
US-5359131-A Sulfonic acid derivatives in the treatment of viral diseases MERRELL DOW PHARMACEUTICALS INC. (US) 1994-10-25 — — US disclosed
Send feedback